AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹14 Cr | ₹7.19 Cr | ₹6.86 Cr | - | - |
What is the latest Contingent Liabilities ratio of AARTI PHARMALABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹7.19 Cr |
| Mar2023 | ₹6.86 Cr |
| Mar2022 | - |
| Mar2021 | - |
How is Contingent Liabilities of AARTI PHARMALABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | 93.53 | |
| Mar2024 | ₹7.19 Cr | 4.78 | |
| Mar2023 | ₹6.86 Cr | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹5,857.0 Cr | 1.1% | -10.7% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 1.1% |
-10.7% |
-12.9% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses